Bausch Health Companies Inc (BHC.TO) — the peer cohort
As of 2026-10-09 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Bausch Health Companies Inc ranks 7 of 13 in its cohort on the Closelooknet composite (55/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| BHC.TO Bausch Health Companies Inc | 55 | 65 | 70 | 84 | info | 22% |
| LNTH Lantheus Holdings Inc | 59 | 68 | 72 | 57 | info | 10.5% |
| KNSA Kiniksa Pharmaceuticals Ltd | 56 | 94 | 57 | 21 | ok | 3.8% |
| AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock | 54 | 89 | 56 | 42 | ok | 6% |
| GALDY GALDERMA GROUP AG | 54 | 45 | 57 | 27 | info | 14.1% |
| ALM.MC Almirall S.A. | 53 | 22 | 44 | 69 | warn | 26.9% |
| FAGR.BR Fagron NV | 52 | 40 | 54 | 61 | info | 12.3% |
| APTX.TO Apotex Health Corp | 46 | 29 | 56 | 52 | — | — |
| CURA.TO Curaleaf Holdings Inc. | 30 | 54 | 22 | 26 | — | — |
| HALO Halozyme Therapeutics Inc | 74 | 93 | 94 | 51 | ok | 5.5% |
| BION.SW BB Biotech AG | 73 | 58 | 96 | 81 | info | 13.8% |
| DXCM DexCom Inc | 66 | 81 | 80 | 38 | watch | 8.8% |
| LLY Eli Lilly and Company | 64 | 70 | 91 | 29 | watch | 9.5% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-10-09
Quick answers
Who are Bausch Health Companies Inc's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Lantheus Holdings Inc (LNTH), Kiniksa Pharmaceuticals Ltd (KNSA), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), GALDERMA GROUP AG (GALDY), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Apotex Health Corp (APTX.TO), Curaleaf Holdings Inc. (CURA.TO) and others.
How does BHC.TO score against its peers?
Bausch Health Companies Inc's composite reads 55/100, ranking 7 of 13 in its cohort as of 2026-10-09; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- GALDY GALDERMA GROUP AGindustry
- ALM.MC Almirall S.A.industry
- FAGR.BR Fagron NVindustry
- PRGO Perrigo Company PLCindustry
- UTHR United Therapeutics Corporationindustry
- VTRS Viatris Incindustry
- HCM.L HUTCHMED China Ltdindustry
- ZTS Zoetis Incindustry
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- ELAN Elanco Animal Healthindustry
- DMP.DE Dermapharm Holding SEindustry
- NBIX Neurocrine Biosciences Incindustry
- SFZN.SW Siegfried Holding Ltdindustry
- APTX.TO Apotex Health Corpsector
- CURA.TO Curaleaf Holdings Inc.sector
- HALO Halozyme Therapeutics Incsector
- BION.SW BB Biotech AGsector